Cargando…

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy

Current biomarkers are inadequate prognostic predictors in localized prostate cancer making treatment decision‐making challenging. Previously, we observed that the combination of more variable telomere length among prostate cancer cells and shorter telomere length in prostate cancer‐associated strom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heaphy, Christopher M, Joshu, Corinne E, Barber, John R, Davis, Christine, Lu, Jiayun, Zarinshenas, Reza, Giovannucci, Edward, Mucci, Lorelei A, Stampfer, Meir J, Han, Misop, De Marzo, Angelo M, Lotan, Tamara L, Platz, Elizabeth A, Meeker, Alan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353659/ https://www.ncbi.nlm.nih.gov/pubmed/35836303 http://dx.doi.org/10.1002/cjp2.288

Ejemplares similares

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
por: Julin, B, et al.
Publicado: (2015)

PTEN Loss is Associated with Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy
por: Lotan, Tamara L., et al.
Publicado: (2014)

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era
por: Chen, Maxine M., et al.
Publicado: (2020)

Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostate
por: Ertunc, Onur, et al.
Publicado: (2023)

A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer
por: Li, Haojie, et al.
Publicado: (2007)

Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer?
por: Weber, Kari A., et al.
Publicado: (2016)

Association of Tumor Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate Cancer
por: Kaur, Harsimar B., et al.
Publicado: (2018)

Post-diagnostic health behaviour scores in relation to fatal prostate cancer
por: Graff, Rebecca E., et al.
Publicado: (2022)

Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer
por: Fang, Fang, et al.
Publicado: (2011)

Circulating Insulin-Like Growth Factor 1–Related Biomarkers and Risk of Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2021)

Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study
por: Zhang, Yiwen, et al.
Publicado: (2022)

Health inequity drives disease biology to create disparities in prostate cancer outcomes
por: Nelson, William G., et al.
Publicado: (2022)

The potential utility of telomere-related markers for cancer diagnosis
por: Heaphy, Christopher M, et al.
Publicado: (2011)

Consumption of Fish Products across the Lifespan and Prostate Cancer Risk
por: Torfadottir, Johanna E., et al.
Publicado: (2013)

Cigarette Smoking and Prostate Cancer Mortality in Four US States, 1999–2010
por: Jones, Miranda R, et al.
Publicado: (2016)

Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
por: Fall, Katja, et al.
Publicado: (2009)

Transcriptional landscape of PTEN loss in primary prostate cancer
por: Imada, Eddie Luidy, et al.
Publicado: (2021)

Nut consumption and prostate cancer risk and mortality
por: Wang, Weike, et al.
Publicado: (2016)

Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia
por: Lotan, Tamara L., et al.
Publicado: (2012)

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression
por: Graff, Rebecca E, et al.
Publicado: (2016)

Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years
por: Plym, Anna, et al.
Publicado: (2022)

Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer
por: Mendes, Adrianna A., et al.
Publicado: (2022)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

Prostate Cancer Mortality Associated with Aggregate Polymorphisms in Androgen-Regulating Genes: The Atherosclerosis Risk in the Communities (ARIC) Study
por: Prizment, Anna E., et al.
Publicado: (2021)

Digitate Tumours of the Prostate, Prostatectomy
por: Clark, Somerton
Publicado: (1914)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Molecular sampling of prostate cancer: a dilemma for predicting disease progression
por: Sboner, Andrea, et al.
Publicado: (2010)

Predicting biochemical recurrence of prostate cancer with artificial intelligence
por: Pinckaers, Hans, et al.
Publicado: (2022)

Optimizing the Management of High-Risk, Localized Prostate Cancer
por: Sundi, Debasish, et al.
Publicado: (2012)

Laparoscopic simple prostatectomy with prostatic urethra preservation for benign prostatic hyperplasia
por: Xing, Nianzeng, et al.
Publicado: (2012)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
por: Xu, Junfeng, et al.
Publicado: (2020)

Long-Term Survival and Causes of Death After Diagnoses of Common Cancers in 3 Cohorts of US Health Professionals
por: Cheng, En, et al.
Publicado: (2022)

Recent advances in prostatectomy for benign prostatic hyperplasia
por: Te, Alexis E.
Publicado: (2019)

The association of diabetes with risk of prostate cancer defined by clinical and molecular features
por: Feng, Xiaoshuang, et al.
Publicado: (2020)

Outcome of radical prostatectomy in primary circulating prostate cell negative prostate cancer
por: Murray, Nigel P, et al.
Publicado: (2016)

The telomere length landscape of prostate cancer
por: Livingstone, Julie, et al.
Publicado: (2021)

Germline Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes after Radiation Therapy for Prostate Cancer: Results from a Test and Validation Set Analysis
por: Margalit, Danielle N., et al.
Publicado: (2015)

AB205. Open prostatectomy vs. laparoscopic prostatectomy for benign prostatic hyperplasia with large volume prostate: a meta-analysis
por: Chen, H, et al.
Publicado: (2016)

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
por: Tyekucheva, Svitlana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ed0tvm678sli2v0rikmpnlcm8